The Centers for Medicare & Medicaid Services (CMS) has extended telehealth coverage for Medicare beneficiaries through September 30, 2025, preserving…
Browsing: Clinical Updates
Biosimilars are increasingly transforming inflammatory bowel disease (IBD) care by offering cost-effective alternatives to expensive biologics with comparable safety and…
On April 24, 2025, Medtronic announced a strategic U.S. distribution agreement with Dragonfly™ Endoscopy, Inc. for its advanced Dragonfly™ pancreaticobiliary…
A Phase 3 clinical trial led by Dr. Marwan Fakih at City of Hope has found that combining sotorasib (a…
Guardant Health and Pfizer have entered a multi-year global collaboration to advance Pfizer’s oncology drug development using Guardant’s liquid biopsy…
A randomized trial published in Lancet Gastroenterology & Hepatology found that appendectomy, when added to standard medical therapy, significantly reduced…
Stanford Medicine researchers have developed a groundbreaking RNA-based blood test that can detect cancer, track resistance to treatment, and assess…
Pfizer has discontinued its experimental oral GLP-1 drug, danuglipron, for obesity treatment after a clinical trial volunteer showed signs of…
Eli Lilly’s Oral GLP-1 Drug Orforglipron Shows Strong Results in Phase 3 Trial Eli Lilly’s investigational oral GLP-1 receptor agonist,…
Atmo Biosciences has taken a major step toward commercializing its ingestible gas-sensing capsule after RMIT University officially transferred all intellectual…